# CIRculating CANcer MAster-Protocol

> **NCT05089747** · — · RECRUITING · sponsor: **Hospices Civils de Lyon** · enrollment: 6000 (estimated)

## Conditions studied

- Adult With Solid Cancer

## Interventions

- **BIOLOGICAL:** Blood sampling for biomarker analysis (microRNA, circulating DNA…)

## Key facts

- **NCT ID:** NCT05089747
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-12-05
- **Primary completion:** 2047-12-01
- **Final completion:** 2047-12-01
- **Target enrollment:** 6000 (ESTIMATED)
- **Last updated:** 2023-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05089747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05089747, "CIRculating CANcer MAster-Protocol". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05089747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*